ArticleJournal of pharmaceutical analysis2025

E3 ubiquitin ligase FBXW11-mediated downregulation of S100A11 promotes sensitivity to PARP inhibitor in ovarian cancer.

Ligang Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.